#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Central nervous system lymphoma Congenital pseudarthrosis Pleomorphic liposarcoma Cardiac failure acute Malignant fibrous histiocytoma Hypoxic-ischaemic encephalopathy Haemophilia A with anti factor VIII Pancreatic carcinoma Scedosporium infection Polyneuropathy Uveitis Neonatal alloimmune thrombocytopenia Chondrosarcoma metastatic Cutaneous T-cell lymphoma stage II Subdural haematoma More trials…

    Learn about Rare Diseases

    Paroxysmal nocturnal haemoglobinuria – Trials in Disease Marginal zone lymphoma – Treatment Aicardi-Goutieres syndrome – Treatment Friedreich’s ataxia – Treatment Ewing’s sarcoma recurrent – Basic Information Ornithine transcarbamoylase deficiency – Treatment Waldenstrom’s macroglobulinaemia – Trials in Disease Mucopolysaccharidosis II – Diagnostics Prolymphocytic leukaemia – Trials in Disease Usher’s syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    IDOR-1117-2520C Betula Alba Pollen Extract Ubiquinol ROC-101 HYDROCHLORIDE Englumafusp Alfa Gad20-209-Fsp-A4 Voriconazole Thiopental Sodium Avacopan Histamine Hydrochloride A3907 Selpercatinib LUXDEGALUTAMIDE Amlodipine Besilate VHB937 PRT3789 Piracetam Immunostimulants Protrans Barzolvolimab More therapies…

    Learn about Your Condition

    Cold urticaria Cutaneous lupus erythematosus Bile acid synthesis disorder Hypochondroplasia Glucose tolerance impaired Cluster headache Liposarcoma metastatic Primary biliary cholangitis Conjunctivitis allergic Rhabdomyosarcoma recurrent Metastases to rectum Hairy cell leukaemia recurrent Graves' disease Triple negative breast cancer Vascular dementia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effectiveness and Safety of DNL310 vs Idursulfase for Children and Young Adults with Mucopolysaccharidosis Type II

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Mucopolysaccharidosis II
    Investigated Drugs:
    • Iduronate-2-Sulfatase Fused To A Fc Polypeptide That Binds To The Human Transferrin Receptor
    • Idursulfase
    Belgium Czechia France Germany Italy The Netherlands +2

  • Study of drug combinations including irinotecan, ifosfamide, vincristine, dactinomycin, regorafenib and other agents for children and adults with rhabdomyosarcoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Rhabdomyosarcoma
    Investigated Drugs:
    • Cyclophosphamide
    • Dactinomycin
    • Doxorubicin
    Austria Belgium Czechia Denmark Finland France +10

  • Study on Istradefylline for Reducing Brain Inflammation in Patients with Progressive Multiple Sclerosis

    Recruiting

    2 1 1
    Investigated Drugs:
    • Istradefylline
    Finland

  • Study on Tranexamic Acid for Reducing Blood Loss in Osteoarthritis Patients Undergoing Total Hip Replacement

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Tranexamic Acid
    Denmark

  • Study on the Effects of Intravenous Ferric Derisomaltose in Non-Anemic Iron Deficient Patients with Colorectal Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Iron deficiency
    Investigated Drugs:
    • Ferric Derisomaltose
    • Sodium Chloride
    Denmark

  • Study on the Effects of Semaglutide for Patients with Glaucoma

    Recruiting

    3 1 1
    Investigated Diseases:
    • Glaucoma
    Investigated Drugs:
    • Semaglutide
    Denmark
Previous Page
1 … 419 420 421 422 423 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!